These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4555151)

  • 21. [Intraglomerular coagulation and fibrinolysis in human primary glomerular diseases].
    Shibata K; Dohi K; Fujii Y; Ishikawa H
    Nihon Jinzo Gakkai Shi; 1991 Aug; 33(8):719-29. PubMed ID: 1770632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.
    Goldsmith GH; Saito H; Ratnoff OS
    J Clin Invest; 1978 Jul; 62(1):54-60. PubMed ID: 659637
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo.
    Levi M; Hack CE; de Boer JP; Brandjes DP; Büller HR; ten Cate JW
    J Clin Invest; 1991 Oct; 88(4):1155-60. PubMed ID: 1833421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Biochemical approach to Masugi nephritis--etiology of glomerulonephritis and involvement of the basement membrane].
    Shibata S
    Nihon Rinsho; 1980 Feb; 38(2):402-7. PubMed ID: 7392231
    [No Abstract]   [Full Text] [Related]  

  • 25. Rapidly progressive glomerulonephritis with antibodies against glomerular basement membranes in serum and kidneys.
    Berg R; Bergstrand A; Bergström J; Cunningham R; Tagesson C; Wasserman J
    Clin Nephrol; 1976 Jan; 5(1):37-43. PubMed ID: 765029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization against glomerular basement lamella and mesangial substance.
    Fuchs U; Schade J; von Baehr R
    Acta Histochem Suppl; 1986; 33():251-2. PubMed ID: 3090633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Blood coagulation system and fibrinolysis in glomerulonephritis (review of the literature)].
    Panchenko VM; Gilunova NI; Kozhomkulova BZh
    Lab Delo; 1977; (8):451-4. PubMed ID: 72846
    [No Abstract]   [Full Text] [Related]  

  • 28. Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis.
    Mesnard L; Rafat C; Vandermeersch S; Hertig A; Cathelin D; Xu-Dubois YC; Jouanneau C; Keller AC; Ribeil JA; Leite-de-Moraes MC; Rondeau E
    FASEB J; 2011 Oct; 25(10):3543-53. PubMed ID: 21764994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cellular reactivity to altered glomerular basement membrane in glomerulonephritis.
    Fillit HM; Read SE; Sherman RL; Zabriskie JB; Van de Rijn I
    N Engl J Med; 1978 Apr; 298(16):861-8. PubMed ID: 204868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The kidney and fibrinolysis in man.
    Gibinski K; Nowak A
    Experientia; 1968 Aug; 24(8):787-8. PubMed ID: 5683165
    [No Abstract]   [Full Text] [Related]  

  • 31. In vivo role of factor XII (Hageman factor) in hypercoagulability and fibrinolysis.
    Herold R; Straub PW
    J Lab Clin Med; 1972 Mar; 79(3):397-412. PubMed ID: 5061394
    [No Abstract]   [Full Text] [Related]  

  • 32. Fibrinolytic studies in 13 unrelated families with factor XII deficiency.
    Rodeghiero F; Castaman G; Ruggeri M; Cazzavillan M; Ferracin G; Dini E
    Haematologica; 1991; 76(1):28-32. PubMed ID: 2055558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Benign course of focal-segmental glomerulonephritis due to antibodies to the glomerular basement membrane].
    Belovezhdov N; Vlaĭkova S; Doĭchinov D
    Vutr Boles; 1979; 18(6):62-7. PubMed ID: 524875
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the plasma contact system in the pathogenesis of experimental anti-GBM glomerulonephritis.
    Villaro J; Sánchez Ibarrola A; Purroy A
    Clin Exp Immunol; 1988 Apr; 72(1):98-102. PubMed ID: 3396222
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Haptenic function and metabolism of the disaccharides of the glomerular basement membrane in heterologous nephrotoxic antibody-induced glomerulonephritis in rats].
    Sternberg M; Lagrue G
    Ann Immunol (Paris); 1977; 128C(4-5):905-8. PubMed ID: 900899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Heterogeneity of antibody response to glomerular basement membrane antigen in patients with different forms of glomerulonephritis.
    Doungchawee G; Chalermsanyakorn P; Boonpucknavig S; Boonpucknavig V
    J Med Assoc Thai; 1992 Jan; 75 Suppl 1():25-31. PubMed ID: 1402475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of glomerulonephritis.
    Couser WG
    Kidney Int Suppl; 1993 Jul; 42():S19-26. PubMed ID: 8361123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular lesions induced by interferon.
    Morel-Maroger L
    Transplant Proc; 1982 Sep; 14(3):499-505. PubMed ID: 6217602
    [No Abstract]   [Full Text] [Related]  

  • 39. Chemistry of cross-reactive fragments of streptococcal cell membrane and human glomerular basement membrane.
    Lange CF
    Transplant Proc; 1969 Dec; 1(4):959-63. PubMed ID: 5315611
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of a "single shot" of urokinase on fibrinolytic activities in patients with IgA nephropathy.
    Tomino Y; Miura M; Suga T; Yagame M; Endoh M; Nomoto Y; Sakai H; Itoh K; Ikeda N
    Tokai J Exp Clin Med; 1984 Mar; 9(1):43-7. PubMed ID: 6535301
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.